<DOC>
	<DOCNO>NCT02820740</DOCNO>
	<brief_summary>Multicenter , open-label , prospective design study characterize performance brain laser interstitial thermal therapy ( LITT ) ablation use Monteris NeuroBlate System treatment drug-refractory medial temporal lobe epilepsy subject candidate LITT surgery .</brief_summary>
	<brief_title>Feasibility Study LITT Medical Refractory Epilepsy</brief_title>
	<detailed_description>Monteris sponsor multicenter , open-label , prospective feasibility study characterize performance laser interstitial thermal therapy ( LITT ) use Monteris NeuroBlate System treatment drug-refractory medial temporal lobe epilepsy subject candidate LITT surgery . The NeuroBlate System use precise , high-intensity laser light initiate necrosis abnormal brain tissue thermal ablation limit injury healthy tissue . Unlike traditional brain surgery , LITT require large opening skull . Subjects meet study eligibility criterion sign inform consent form enter Baseline ( pre-surgery ) Phase establish baseline seizure frequency . Subjects , caregiver , require keep seizure diary throughout study , begin first baseline visit . The study monitor record subject ' seizure frequency , antiepileptic medication , physical emotional health . Upon demonstrate required seizure frequency stable antiepileptic medication 3-Month Baseline Phase , subject qualify study procedure . Subjects treat NeuroBlate 2 year follow-up . Throughout study participation , study investigator continuously monitor document effectiveness safety data study appointment .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>Relevant Inclusion Criteria list Diagnosis unilateral medial temporal lobe epilepsy ( MTLE ) confirm clinically either ( 1 ) ictal scalp record MRI evidence mesial temporal sclerosis ( 2 ) intracranial ictal onset consistent hippocampal origin Averages 3 complex partial seizure ( without secondary generalization ) per month Refractory antiepileptic drug ( AEDs ) . Subjects consider refractory fail treatment least 2 AEDs due lack efficacy Meets criteria medial temporal lobe resection candidate LITT 18 year old time consent Relevant Exclusion Criteria list Previous diagnosis psychogenic/nonepileptic seizure Previous diagnosis primary generalize seizure IQ le 70 Subject MRIincompatible implant electronic device metallic prosthesis implant brain MRI contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Medial Temporal Lobe Epilepsy</keyword>
	<keyword>Seizure</keyword>
	<keyword>NeuroBlate</keyword>
	<keyword>LITT</keyword>
	<keyword>Quality Life</keyword>
</DOC>